These Analysts Just Made A Sizeable Downgrade To Their Investcorp Capital plc (ADX:ICAP) EPS Forecasts

One thing we could say about the analysts on Investcorp Capital plc (ADX:ICAP) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization. Revenue and earnings per share (EPS) forecasts were both revised downwards, with analysts seeing grey clouds on the horizon.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

After the downgrade, the four analysts covering Investcorp Capital are now predicting revenues of US$140m in 2026. If met, this would reflect a solid 13% improvement in sales compared to the last 12 months. Statutory earnings per share are presumed to leap 23% to US$0.046. Prior to this update, the analysts had been forecasting revenues of US$159m and earnings per share (EPS) of US$0.064 in 2026. It looks like analyst sentiment has declined substantially, with a substantial drop in revenue estimates and a pretty serious decline to earnings per share numbers as well.

See our latest analysis for Investcorp Capital

Analysts made no major changes to their price target of US$0.58, suggesting the downgrades are not expected to have a long-term impact on Investcorp Capital's valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Investcorp Capital analyst has a price target of US$0.69 per share, while the most pessimistic values it at US$0.48. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Investcorp Capital's past performance and to peers in the same industry. The analysts are definitely expecting Investcorp Capital's growth to accelerate, with the forecast 13% annualised growth to the end of 2026 ranking favourably alongside historical growth of 6.7% per annum over the past three years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 5.6% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Investcorp Capital to grow faster than the wider industry.

The Bottom Line

The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for Investcorp Capital. Unfortunately, analysts also downgraded their revenue estimates, although our data indicates revenues are expected to perform better than the wider market. We're also surprised to see that the price target went unchanged. Still, deteriorating business conditions (assuming accurate forecasts!) can be a leading indicator for the stock price, so we wouldn't blame investors for being more cautious on Investcorp Capital after the downgrade.

Worse yet, our risk analysis suggests that Investcorp Capital may find it hard to maintain its dividend following these downgrades. You can learn more, and discover the 1 possible risk we've identified, for free on our platform here.

Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks with high insider ownership.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.